Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 844, doi. 10.1038/sj.gt.3301157
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2000 AND VI 7 AND IP 10
Results: 12
1
2
Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 886, doi. 10.1038/sj.gt.3301159
- By:
- Publication type:
- Article
3
Adenoviral vector which delivers FasL–GFP fusion protein regulated by the tet-inducible expression system.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 875, doi. 10.1038/sj.gt.3301172
- By:
- Publication type:
- Article
4
Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 826, doi. 10.1038/sj.gt.3301173
- By:
- Publication type:
- Article
5
Antisense ATM gene therapy: a strategy to increase the radiosensitivity of human tumors.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 852, doi. 10.1038/sj.gt.3301174
- By:
- Publication type:
- Article
6
Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 837, doi. 10.1038/sj.gt.3301175
- By:
- Publication type:
- Article
7
Efficiency of transgenic T cell generation from gene-marked cultured human CD34<sup>+</sup> cord blood cells is determined by their maturity and the cytokines present in the culture medium.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 830, doi. 10.1038/sj.gt.3301176
- By:
- Publication type:
- Article
8
Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 896, doi. 10.1038/sj.gt.3301177
- By:
- Publication type:
- Article
9
Anti-inflammatory action of type I interferons deduced from mice expressing interferon β.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 817
- By:
- Publication type:
- Article
10
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 859, doi. 10.1038/sj.gt.3301184
- By:
- Publication type:
- Article
11
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.
- Published in:
- Gene Therapy, 2000, v. 7, n. 10, p. 867, doi. 10.1038/sj.gt.3301205
- By:
- Publication type:
- Article
12
A tale of two trials: selectively replicating herpesviruses for brain tumors.
- Published in:
- 2000
- By:
- Publication type:
- Editorial